Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019

1
Chemotheraphy Induced Nausea and Vomitting Drugs
(CINV) Market Analysis, (2015-2019)
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
2
Report Overview
CINV is one of the most dreaded adverse effects
of chemotherapy. It often leads to the
postponement or refusal of potentially curative
chemotherapy treatment for cancer. This nausea
and vomiting, associated with chemotherapy
regimen, affects the quality of life of an
individual. The neurotransmitters in CINV are
dopamine, 5-HT3, substance P, and
endocannabinoids. CINV can be caused by the
stimulation of vomiting center by the abdominal
vagal afferents or by the direct stimulation of
CTZ in the area postrema. The risk of development
of CINV changes with the use of different types
of chemotherapy regimens such as high, moderate,
low, and minimal risk.
3
Report Overview
Based on the type of CINV, different treatment
regimens are prescribed. The classes of drugs
used in the treatment of CINV are 5-HT3 receptor
antagonists, NK1 receptor antagonists,
corticosteroids, dopamine antagonists,
benzodiazepines, and cannabinoids. Most of the
drugs used in the treatment are helpful in the
prevention of vomiting but show less effect in
treating nausea. Technavios analysts forecast
the global chemotherapy induced nausea and
vomiting drugs market to grow at a CAGR of 4.9
over the period 2014-2019. Enquire about report
at http//www.researchbeam.com/global-chemothera
phy-induced-nausea-and-vomitting-cinv-drugs-2015-2
019-market/enquire-about-report
4
Report overview
The report covers the present scenario and the
growth prospects of the global CINV drugs market
for the period 2015-2019. To calculate the market
size, the report considers revenue generated from
the sales of various branded therapies and
generics along with the drugs used as off-label
for the treatment of CINV. Technavios report,
Global CINV Drugs Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, APAC, and EMEA it also
covers the landscape of the global CINV drugs
market and its growth prospects in the coming
years. The report includes a discussion of the
key vendors operating in this market.
5
Report Overview
Key regions Americas APAC EMEA Key
vendors GlaxoSmithKline Helsinn Heron
Therapeutics Merck and Co Tesaro
6
(No Transcript)